高级检索
当前位置: 首页 > 详情页

A core-shell liquid metal-Cu nanoparticle with glutathione consumption via an in situ replacement strategy for tumor combination treatment of chemodynamic, microwave dynamic and microwave thermal therapy.

文献详情

资源类型:
Pubmed体系:
机构: [1]College of Biomedical Engineering, Sichuan University, Chengdu 610065, China. [2]Laboratory of Controllable Preparation and Application of Nanomaterials, Technical Institute of Physics and Chemistry, Chinese Academy of Sciences, Beijing 100190, China. [3]CAS Key Laboratory of Cryogenics, Technical Institute of Physics and Chemistry, Beijing 100190, China. [4]Department of Radiology, First Hospital of China Medical University, Shenyang 110001, China. [5]Department of Oncology, Renmin Hospital of Wuhan University, Wuhan 430060, China.
出处:
ISSN:

摘要:
The presence of high content glutathione (GSH) provides an effective "protective shield" for tumor cells, which undoubtedly is a huge impediment to reactive oxygen species (ROS)-based treatment. Fortunately, divalent copper (Cu2+) can not only consume GSH, destroying the protection mechanism of GSH, but also can be reduced to Cu+ with excellent Fenton-like reaction activity. Hence, capitalizing on the properties of liquid metals, we introduced Cu with three different valances via an in situ replacement reaction. A stable core-shell liquid-metal based "Cu storage pool" was obtained. It can effectively deplete GSH within the cells, and simultaneously produce ·OH through a Fenton-like reaction, further improving the effect of chemodynamic therapy (CDT). Under microwave irradiation, it is also capable of producing a large amount of ROS to promote tumor treatment. In addition, the loading of ionic liquid endows LZC@IL nanoparticles with certain microwave heating performance, which is able to augment microwave thermal therapy (MWTT). With the combination of CDT, microwave dynamic therapy (MDT) and MWTT, LZC@IL has an excellent effect on tumor elimination. This work offers a new idea for the application of liquid metals and the combined treatment of tumors, which has potential application value.

基金:
语种:
PubmedID:
中科院(CAS)分区:
出版当年[2022]版:
大类 | 2 区 工程技术
小类 | 2 区 材料科学:生物材料
最新[2023]版:
大类 | 3 区 医学
小类 | 3 区 材料科学:生物材料
第一作者:
第一作者机构: [1]College of Biomedical Engineering, Sichuan University, Chengdu 610065, China. [2]Laboratory of Controllable Preparation and Application of Nanomaterials, Technical Institute of Physics and Chemistry, Chinese Academy of Sciences, Beijing 100190, China. [3]CAS Key Laboratory of Cryogenics, Technical Institute of Physics and Chemistry, Beijing 100190, China.
通讯作者:
通讯机构: [2]Laboratory of Controllable Preparation and Application of Nanomaterials, Technical Institute of Physics and Chemistry, Chinese Academy of Sciences, Beijing 100190, China. [3]CAS Key Laboratory of Cryogenics, Technical Institute of Physics and Chemistry, Beijing 100190, China.
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:43389 今日访问量:0 总访问量:3120 更新日期:2024-09-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 四川省肿瘤医院 技术支持:重庆聚合科技有限公司 地址:成都市人民南路四段55号